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ultrasound was the most common imaging procedure both 12 months pre- and 
36 months post-index (31.0%, 54.6%, respectively), followed by abdominal/pelvic 
ultrasound (27.3%, 49.6%, respectively). ConClusions: Approximately one-third of 
women with newly diagnosed uterine fibroids underwent hysterectomy within the 
first year of initial diagnosis. Minimally invasive procedures such as hysteroscopic 
myomectomy were infrequently utilized, despite published evidence showing con-
siderably lower costs and complication rates over hysterectomy.
PMD5
CoMParative effeCtiveness of fibrin sealants in CarDiaC surgery
Arnold M.R.1, Ito D.1, Magee G.2, Xiong Y.1, Testa D.3, Rubinstein M.1, Tackett S.1
1Baxter Healthcare Corporation, Westlake Village, CA, USA, 2Premier Incorporated, Charlotte, NC, 
USA, 3Seven of Nine Systems, Studio City, CA, USA
objeCtives: While effectiveness of fibrin sealants for controlling bleeding in car-
diac surgery has been demonstrated, there is a paucity of research on other clinical 
outcomes of fibrin sealants. In this retrospective observational study we analyzed 
the clinical outcomes of two different fibrin sealants in a population of patients 
undergoing cardiac surgical procedures. Methods: Data from patients undergoing 
coronary artery bypass grafting (CABG), valve and valvular procedures with CABG 
during the years 2008 - 2012 were extracted from Premier’s Hospital Database. The 
Premier Hospital Database is a comprehensive database containing data from over 6 
million US hospital discharges annually. Only surgeries in which a fibrin sealant was 
utilized were included; all other hemostatic agents were excluded from the study. The 
following clinical outcomes were assessed: major and minor complications, transfu-
sions, surgical revisions for bleeding, operative mortality (hospitalization), OR time 
and hospital and ICU length of stay (LOS). Logistic regression analyses were performed 
on categorical outcome variables and GLM regression analyses were performed on 
continuous outcome variables. Study covariates included: age, primary procedure, 
Charlson Co-morbidity Index (CCI) score, heparin use, protamine use, admission type, 
gender, race, teaching hospital, bed size and region. Results: A total of 2,560 inpa-
tient cardiac procedures using fibrin sealant with synthetic aprotinin (FS-apr) were 
compared to 1,019 procedures using fibrin sealant without aprotinin (FS). Results 
suggested that FS-apr was associated with significantly lower rates of minor compli-
cations (21.1% vs. 27.1%, p = 0.002), Day 1 Transfusions (28.6% vs. 36.8%, p = 0.015) and 
ICU LOS (4.7 days vs 7.1 days, p < 0.0001) as compared to FS. No significant differences 
were found between FS-apr and FS on the other clinical outcomes. ConClusions: 
FS-apr was associated with signficantly lower rates of Day 1 Transfusions, avoidable 
minor complications and lower average ICU LOS as compared to FS.
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objeCtives: Peripheral Blood Transplant (PBT) accounted for three-quarters of 
the Hematopoietic Cell Transplant (HCT) from unrelated donors in the past dec-
ade, which indicates it has largely replaced Bone Marrow Transplant (BMT) as 
the preferred graft source. This shift occurred due to evidence suggesting faster 
neutrophil and platelet engraftment with the former. However, clinical evidence 
favoring PBT for other outcomes is inconclusive. Although meta-analyses have 
compared outcomes for PBT and BMT from related donors, no such analysis has 
been conducted for unrelated donor procedures. Our objective is to conduct a 
meta-analysis comparing the outcomes in patients undergoing allogeneic unre-
lated donor HCT comparing PBTvs.BMT. Methods: We conducted a systematic 
literature search(PUBMED,CANCERLIT and Cochrane databases) identifying rand-
omized trials and retrospective studies comparing outcomes of allogeneic unrelated 
donor PBTvs.BMT. We extracted longitudinal transplant outcomes, including acute 
graft-versus-host disease(GVHD) grade II to IV(aGVHD), chronic GVHD(cGVHD), 
overall-survival(OS), transplant-related mortality(TRM), disease-free survival(DFS) 
and relapse from published Kaplan-Meier curves. We used the inverse variance 
method(Cochrane RevMan5.3.5) to estimate pooled hazard ratios(HRs) and 95% con-
fidence-intervals(CI). HR value< 1.00 for an outcome signified PBT as the favorable 
option compared to BMT. Results: One randomized trial and five retrospective 
studies were included in the analysis. PBT was significantly less favorable than BMT 
on aGVHD [HR(1.30),CI(1.15 to 1.47)] and cGVHD [HR(1.32), CI(1.16 to 1.49)]. We did-
not find statistically significant differences in other outcomes:OS [HR(1.02),CI(0.86 
to 1.21)], DFS [HR(1.00),CI(0.91 to 1.10)], Relapse [HR(1.02,CI (0.78 to 1.34)] and TRM 
[HR(0.98),CI(0.77 to 1.24)]. ConClusions: Although PBT is the predominant mode 
of allogeneic HCT, our meta-analysis found no outcomes for which PBT is favorable 
compared to BMT. The only statistically significant comparisons indicated increased 
hazard of acute and chronic GVHD with PBT. While PBT may offer other clinical 
advantages over BMT that merit weight in clinical decision-making, its failure to 
demonstrate significant improvements in overall survival, disease-free survival 
and transplant-related mortality and increased risk of GVHD calls current clinical 
practice into question.
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patients subjected to PMs implantation, initial or replacement, in our center compared 
with others studies. In the case of ICD implantations, initials or replacements, there 
weren’t any adverse event. The additional hospitalization days and cost attributed 
to these adverse events depends on the nature of adverse event.
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objeCtives: Research on prognostic factors of ventricular arrhythmias inducibility 
in patients with severe reduced LV systolic function being ICD candidates for primary 
prevention of sudden cardiac death has given limited results so far. Aim of our study 
was to examine the relationship of specific echocardiographic markers, beyond LV 
ejection fraction, particularly left ventricular hypertrophy and left ventricular end-
diastolic diameter, with ventricular arrhythmias inducibility during electrophysiologi-
cal study in patients with ischemic cardiomyopathy. Methods: Data were acquired 
from patients with ischemic cardiomyopathy and severe reduced LV systolic function 
who underwent electrophysiological in the context of primary prevention of sud-
den cardiac death. Electrophysiological study protocol included programmed elec-
trical stimulation from right ventricular apex. Results: Of 119 patients included, 
ventricular arrhythmias were induced in 76 (63.9%). Prior echocardiographic study 
revealed 26 (21%) patients with ventricular hypertrophy (defined as interventricular 
septum and posterior wall diastolic thickness > 11mm) and 90 patients (76.3%) with 
dilated left ventricle (defined as LV end-diastolic diameter > 55 mm). 80% of patients 
with left ventricular hypertrophy had ventricular arrhythmias induced compared 
to 59% of patients without ventricular hypertrophy (p< 0.05). However, as regards 
LV end-diastolic diameter, difference between groups was not statistically signifi-
cant (p= 0.92). ConClusions: In populations at high risk for sudden cardiac death, 
such as ischemic cardiomyopathy patients, ventricular hypertrophy is correlated to 
ventricular arrhythmias inducibility and possibly is a risk factor for spontaneous 
malignant arrhythmias.
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objeCtives: To compare QFT-GIT to TST in detection of latent TB infection among 
National Guard general population in Saudi Arabia. Methods: a total of 1369 subjects 
chosen randomly from the catchment areas of PHC centers of national Guard Health 
Affairs in Saudi Arabia. inclusion criteria were Saudi national, age 5 years or more, 
resident of Saudi Arabia and availability during the study. Exclusion criteria included 
age less than 5 years (to avoid the BCG vaccination effect on the results ), present or 
previous active tuberculosis, those already diagnosed of having LTBI &/ or on anti TB 
prophylaxis & all immunocompromised conditions. Blood was drawn and processed 
using QFT-GIT followed by immediate administration of TST solution on subjects fore-
arm. Data were collected and analyzed using SPSS software. Results were compared 
using the chi-square test & kappa coefficient was calculated. Results: both tests 
had a significant overall agreement of 88.8% (k= 0.332; p< 0.001). Negative concordance 
represented 85.2% and positive concordance represented 3.6% . Positive QFT-GIT but 
negative TST was 5.5% of the results while positive TST but negative QFT-GIT was 
5.7% of the results. Concordance was associated significantly with younger ages and 
female gender. Positive results in both tests were significantly associated with older 
ages and male gender only in 15-44 years age group. ConClusions: The overall 
agreement of TST & QFT-GIT among Saudi National Guard general population was 
88.8% for detection of LTBI. In absence of a gold standard, QFT-GIT showed acceptable 
results compared to TST for detecting LTBI in intermediate TB burden country with 
at birth BCG highly vaccinated population.
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objeCtives: To describe treatment patterns and diagnostic pathways for women 
with uterine fibroids up to three years following a new diagnosis. Methods: 
Patients with a new diagnosis of uterine fibroids (ICD-9 code: 218.9) were identi-
fied in the Truven Health MarketScan Research Databases from 2004-2013. The use 
of specific diagnostic and treatment procedures and medications were described 
in the 12 months prior to (pre-index) and in the 12, 24 and 36 months following 
(post-index) the diagnosis (index event). Patients were required to have continuous 
enrollment throughout the pre- and post-index periods. Results: A total of 359,672 
patients met the selection criteria with mean age 46.1 years (SD= 9.3) at first diag-
nosis. Of those, subsets of 244,827 (68.1%) patients and 164,645 (45.8%) patients had 
24 and 36 months of post-index follow-up, respectively. Hysterectomy was the most 
common surgical intervention, increasing from 29.3% in the first 12 months to 35.5% 
in the first 36 months; average time to hysterectomy was 49.7 days. Other surgical 
interventions used within the first 12 months of follow-up included: endometrial 
ablation (5%), curettage (3.6%), and either hysteroscopic myomectomy, laparascopic 
myomectomy, abdominal myometcomy, or uterine emobolization (< 2% each). 13.1% 
of women used hormonal birth control with higher rates among younger women. 
IUDs or Gnrh agonists were used by approximately 1% of women. Transvaginal 
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shocks but secondary prevention patients showed a higher rate of appropriate 
therapy.
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objeCtives: Identify patient and clinical characteristics in the diabetic foot ulcer 
(DFU) population and examine patterns of cellular/tissue derived product (CTP) 
utilization. Methods: Retrospective, de-identified electronic medical records 
from 2007-2013 were extracted from the Intellicure Limited Data Set (I-LDS). The 
I-LDS extracts records from 96 hospital-based outpatient wound centers. Patient, 
wound and encounter level characteristics were examined. CTPs of interest included 
extracellular matrix (ECM), human skin equivalent (HSE), and living skin equivalent 
(LSE). Results: A total of 10,359 patients, 21,677 wounds, and 222,861 encoun-
ters for DFU were identified. The majority of patients was male (60.9%), Caucasian 
(63.5%), and reported Medicare as their primary insurance (51.1%). The average age 
was 63.9 (SD= 13.5) and the average number of physician visits was 17.4 (SD= 20.8). 
The mean wound surface area was 5.6 cm2 (SD= 27.3). The overall average wound 
age was 7.0 months (SD= 16.26). Of the 21,677 wounds, approximately 8.6% received 
ECM (2.6%), HSE (2.6%), or LSE (3.4%). The average number of applications for ECM 
was 2.7 (SD= 2.5), 2.0 (SD= 1.7) for HSE, and 4.0 (SD= 2.9) for LSE. Wounds treated with 
CTPs were, on average, several months older relative to the overall DFU population: 
16.0, 16.4, and 14.7 months for ECM, HSE, and LSE, respectively. Overall average 
wound treatment time was 3.4 months (SD= 8.4). However, treatment time was 
substantially longer with CTP utilization with an average time of 9.1, 9.3, and 8.0 
months for ECM, HSE, and LSE, respectively. ConClusions: CTP utilization was 
relatively low within outpatient wound centers. Results from this analysis indicate 
that health care providers are using CTPs on older, more difficult-to-heal DFUs.
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objeCtives: Identify patient and clinical characteristics in the DFU population 
and examine patterns of hyperbaric oxygen therapy (HBOT), negative pressure 
wound therapy (NPWT), and becaplermin gel utilization. Methods: Retrospective, 
de-identified electronic medical records from 2007-2013 were extracted from the 
Intellicure Limited Data Set (I-LDS). The I-LDS extracts records from 96 hospital-
based outpatient wound centers. Patient, wound and encounter level character-
istics were examined. Utilization of advanced therapies including HBOT, NPWT, 
and becaplermin gel were analyzed. Results: A total of 10,359 patients, 21,677 
wounds, and 222,861 encounters for DFU were identified. The majority of patients 
was male (60.9%), Caucasian (63.5%), and reported Medicare as their primary insur-
ance (51.1%). The average age was 63.9 (SD= 13.5) and the average number of evalua-
tion and management visits was 21.9 (SD= 26.9). Mean wound surface area was 5.6 
cm2 (SD= 27.3). Of the 10,359 patients, approximately 28.2% received HBOT, 16.0% 
received NPWT, and 4.1% received becaplermin gel. Average number of HBOT visits 
was 31.7 (SD= 24.9) and 1.2 (SD= 0.6) episodes for NPWT. The average number of 
becaplermin days was 81.7 (SD= 113.2). Of the 21,677 wounds, the overall average 
wound treatment time was 3.4 months (SD= 8.4). The reported risk of amputation 
was lower in wounds treated with becaplermin (3.3%) compared to the overall popu-
lation (5.3%), problems treated with NPWT (5.6%) and HBOT (9.8%), respectively. 
Wounds treated with becaplermin were more likely to heal (46.3%) relative to the 
overall population (41.1%), problems treated with NPWT (27.5%) and HBOT (32.2%), 
respectively. ConClusions: Advanced therapy utilization varied within outpatient 
wound centers. Results from this analysis indicate that health care providers are 
using advanced therapies on difficult-to-heal DFUs.
PMD12
exaMination of interval inCiDenCe of ColoreCtal CanCer (CrC) at 
subsequent ColonosCoPy over tiMe: PoPulation-baseD retrosPeCtive 
Cohort stuDy
Ren J.1, Asche C.V.1, Kirkness C.S.1, Puli S.2
1University of Illinois College of Medicine at Peoria, Peoria, IL, USA, 2OSF Medical Group, Peoria, 
IL, USA
objeCtives: Evidence for surveillance intervals of colonoscopy are primarily 
based on adenoma recurrence rather than on CRC incidence. Current evidence 
suggests that due to the overuse of surveillance colonoscopy among low-risk 
patients and the underuse among high-risk patients the recommended surveil-
lance intervals may need adjustment. This study aims to tailor surveillance inter-
vals by estimating incidence of CRC at subsequent colonoscopy under diverse 
circumstances. Methods: A population-based, retrospective cohort study of 
patients with a colonoscopy between January 2010 and March 2014 were identi-
fied in a well-administrated database of colonoscopy screening and surveillance. 
The data includes patient demographics, family history of CRC, and the pathology 
result (including date) of previous and current colonoscopies. Adjusted Weibull 
regression models estimated the incidence rate of CRC at subsequent colonos-
copy given any proper interval and risk (level and coexisting). Levels of risk for 
patients without CRC, based on baseline colonoscopy, were: High Risk (≥ 3, large 
or advanced adenoma), Medium risk and Low risk (no polyp). Coexisting risk was 
defined by a combination of two the three levels: a) an incomplete polyp removal, 
b) a ≥ 3 adenoma at last colonoscopy, C) a personal history of CRC. Results: 
Among total 27,325 patients, the prevalence of CRC at baseline colonoscopy was 
8.2% for the patients with follow-up. The benchmark risk was determined by the 
overall interval incidence of CRC (0.33%) for low risk patients. Men and women 
with high risk or CRC history exceeded this benchmark in approximately 5 and 10 
objeCtives: Implantable cardioverter defibrillator (ICD) is considered a lifelong 
therapy for the prevention of sudden cardiac death. However, it is still unresolved 
if patients who never experienced an appropriate ICD intervention during first gen-
erator longevity really need to undergo device replacement. Methods: In a single-
center prospective observational cohort study we examined the time-dependence of 
first appropriate ICD therapy for ventricular arrhythmias in patients who underwent 
ICD implantation for primary prevention. Primary prevention ICD patients were 
enrolled at the time of their first implantation and were evaluated thereafter for the 
first occurrence of appropriate ICD therapy for ventricular arrhythmias. Results: 
Of 623 ICD recipients, 126 (20,2%) had appropriate ICD therapy. Incidence of first 
appropriate ICD therapy was 8.2% in the first year post-implant, increased to 13.7% 
in year 2, while in year 5 it was 28.3% (fig 1). Notably 39 patients received their 
first appropriate therapy after device replacement. No predictive factors for lower 
need of ICD therapy could be identified in patients without prior appropriate ICD 
intervention. ConClusions: In a primary prevention population the risk of first 
appropriate ICD therapy persists over long lifetime and necessitates continuing 
device therapy irrespective of shock-free intervals.
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objeCtives: We investigated prospectively whether serum markers of collagen 
turnover could be used as predictors for the occurrence of malignant ventricu-
lar arrhythmias in patients with non-ischemic dilated cardiomyopathy (NIDC) 
implanted with an implantable cardioverter defibrillator (ICD) for primary preven-
tion. Extracellular matrix (ECM) alterations in NIDC may provide electrical hetero-
geneity, thus potentially contributing to the occurrence of ventricular arrhythmia 
and subsequent SCD. Methods: Serum C-terminal propeptide of collagen type-I 
(CICP), C-terminal telopeptide of collagen type-I (CITP), matrix metalloproteinase 
(MMP)-1, and tissue inhibitor of matrix metalloproteinases (TIMP)-1 were measured 
as markers of collagen synthesis and degradation in 70 patients with mildly to 
moderate symptomatic heart failure due to NIDC with LVEF < 35%, who received 
an ICD for primary prevention of SCD. Patients were evaluated for any appropriate 
ICD delivered therapy, whether shock or antitachycardia pacing, during a 1-year 
follow-up period. Results: Appropriate device therapies were delivered in 14 of the 
70 patients during the follow-up period, with antitachycardia pacing in 2, antitachy-
cardia pacing with shocks in 4, and shocks in 8. Preimplantation MMP-1 levels were 
significantly higher in patients who had appropriate ICD-delivered therapy than 
in those who did not have any therapy (27.7±1.6 ng/ml vs. 24.1±2.5 ng/ml, respec-
tively, p< 0.001). The same was true for baseline serum concentrations of TIMP-1 
and CITP (89±14 ng/ml vs. 58±18 ng/ml, p= 0.008 and 0.46±0.19 ng/ml vs. 0.19±0.07 
ng/ml, p< 0.001, respectively). ConClusions: Undoubtedly, ECM alterations play a 
crucial role in the constitution of an arrhythmogenic substrate in NIDC and, given 
the availability of therapies to prevent fatal ventricular tachyarrhythmias, the quest 
for factors that have a very good correlation with appropriate ICD discharges in 
these patients is logical. Our results confirm the role of serum markers of collagen 
turnover as predictors of arrhythmic events in ICD recipients and could provide an 
auxiliary tool in this context.
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objeCtives: The beneficial effects of implantable cardioverter defibrillators (ICDs) 
in primary and secondary prevention patients are well established. However, 
relative scarcity of data exists regarding long-term follow-up outcomes of this 
population in the context of tertiary hospitals-ICD implantation centres beyond 
randomized clinical trials borders. The aim of the study was to exhibit “real-world” 
data and possible differences on mortality and ICD therapies between secondary 
and primary prevention ICD recipients. Methods: All patients treated with an 
ICD, regardless of the underlying cardiac pathology, at the island of Crete were 
included in the current analysis. The study population was grouped by the type of 
prevention (secondary or primary) for sudden cardiac death. The primary endpoint 
was all-cause mortality. The secondary endpoint was the occurrence of device 
therapy (appropriate or inappropriate). Results: A total of 854 (88.6% men) ICD 
recipients were included. Of these, 623 (73%) patients received an ICD for pri-
mary prevention of sudden cardiac death and 231 (27%) patients for secondary 
prevention. During a mean follow-up of 12,4 +/-7,8 years, 177 (20.7%) patients 
died. The incidence of mortality was 35,5% for secondary prevention patients and 
15.2% for primary prevention patients (p< 0.001). Ventricular arrhythmia triggered 
appropriate therapy in 91 (39,4%) secondary prevention patients. Accordingly the 
number of primary prevention patients that received appropriate therapy was 126 
(20,2%). A comparable risk for inappropriate shocks was observed. ConClusions: 
During long-term follow-up, primary prevention patients exhibited a lower risk 
for all-cause mortality. Both groups showed similar occurrence of inappropriate 
